A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
271 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitario Austral
Pilar, B, Argentina
- "centro de Educación Médica E Investigaciones Clínicas ""norberto Quirno"""
Ciudad Autonoma Buenos Aires, Buenos Aires F.D., Argentina
- Hospital Italiano de Buenos Aires
Ciudad Autonoma Buenos Aires, Buenos Aires F.D., Argentina
- Sanatorio Allende
Córdoba, Argentina
- Calvary Mater Newcastle
Waratah, New South Wales, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Box Hill Hospital
Box Hill, Victoria, Australia
- Monash Health
Clayton, Victoria, Australia
- Ordensklinikum Linz Elisabethinen
Linz, Austria
- Universitätsklinikum St. Pölten
Sankt Pölten, Austria
- Hanusch-Krankenhaus
Vienna, Austria
- Medizinische Universitaet Wien - Universitaetsklinik Fuer Augenheilkunde Und Optometrie
Vienna, Austria
- Grand Hopital de Charleroi - Les Viviers
Charleroi, WHT, Belgium
- Az Groeninge - Campus Kennedylaan
Kortrijk, Belgium
- Chn - Complexo Hospitalar de Niteroi
Niterói, Rio de Janeiro, Brazil
- Instituto Nacional de Câncer
Rio de Janeiro, Rio de Janeiro, Brazil
- Hospital Das Clínicas Da Faculdade de Medicina de Ribeirão Preto Da Universidade de São Paulo
Ribeirão Preto, São Paulo, Brazil
- Clinica Medica Sao Germano
São Paulo, São Paulo, Brazil
- Hospital Santa Marcelina
São Paulo, São Paulo, Brazil
- Hospital Das Clínicas Da Faculdade de Medicina Da Universidade de São Paulo
São Paulo, São Paulo, Brazil
- Hospital de Câncer de Barretos - Fundação Pio Xii
Barretos, Brazil
- Hospital Mãe de Deus
Porto Alegre, Brazil
- Instituto Coi de Pesquisa, Educação E Gestão
Rio de Janeiro, Brazil
- Hospital São Rafael
Salvador, Brazil
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Local Institution - 0208
Ottawa, Ontario, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- Chuq - the Hôtel-Dieu de Québec
Québec, Quebec, Canada
- Fundación Arturo López Pérez
Santiago, Chile
- Local Institution - 0258
Temuco, Chile
- Clinica Alemana - Vitacura
Vitacura, Chile
- Anhui Provincial Hospital
Hefei, AH, China
- Local Institution - 0326
Beijing, BJ, China
- the Fifth Medical Center of People'S Liberation Army General Hospital
Beijing, Beijing Municipality, China
- Local Institution - 0321
Chongqing, CQ, China
- the First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
- Nanfang Hospital of Southern Medical University
Guangzhou, GD, China
- Guangdong Provincial People'S Hospital
Guangzhou, Guangdong, China
- Shenzhen Second People'S Hospital
Shenzhen, Guangdong, China
- the Third Xiangya Hospital of Central South University
Changsha, HN, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Jun 2023
- Primary completion
- 15 Mar 2029
- Completion
- 1 Jan 2036
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 1,230
- Registry id
- NCT05827016
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.